Diminished HSD11B1 activity has been previously reported in PCOS [27,28,29,30] and may result in a shift of steroidogenesis towards the more active glucocorticoid products associated with hypercortisolemic adverse effects often manifesting as the metabolic syndrome. The gene discussed is HSD11B1; the disease is polycystic ovary syndrome.